SEC Form 4 · accession 0001437749-16-028814
RESPONSE BIOMEDICAL CORP · RBM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J. Adams
Officer — CFO & Corporate Secretary
Period of report
Mar 29, 2016
Accepted (ET)
Mar 31, 2016 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806888
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.60 | Mar 29, 2016 | A | 25,000 | A | Mar 29, 2016 | Dec 21, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On December 22, 2015, the reporting person was granted an option to purchase 25,000 shares of common stock. The option vests upon the satisfaction of certain performance criteria; provided such criteria is met on or before June 30, 2016. This performance criteria was met, resulting in the vesting of the option in full.